Institut Cochin   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Paris France (2002)

Organization Overview

First Clinical Trial
2005
NCT00235183
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Centre d'Investigation en Médecine du Sport, Hôpital Hôtel Dieu, APHP | Cochin, AP-HP, Paris | Hôpital Cochin, Paris | Hôpital Cochin - Paris - France | Hôpital Cochin, Paris, France

Active Ingredients

Drugs in Phase 4 Trials (4)

amino acids (Freamine) (1 trial)

blood plasma (1 trial)

ferric carboxymaltose (Injectafer) (1 trial)

fumaric acid esters (1 trial)

Drugs in Phase 2 Trials (1)

peys606 (1 trial)

Drugs in Phase 1 Trials (2)

imcy-0098 (1 trial)

mym-v101 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Malnutrition (Phase 4)

Panuveitis (Phase 2)

Uveitis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7